Abstract. A comparison of dengue virus (DENV) antibody levels in paired serum samples collected from predominantly DENV-naive residents in an agricultural settlement in Brazilian Amazonia (baseline seroprevalence, 18.3%) showed a seroconversion rate of 3.67 episodes/100 person-years at risk during 12 months of follow-up. Multivariate analysis identified male sex, poverty, and migration from extra-Amazonian states as significant predictors of baseline DENV seropositivity, whereas male sex, a history of clinical diagnosis of dengue fever, and travel to an urban area predicted subsequent seroconversion. The laboratory surveillance of acute febrile illnesses implemented at the study site and in a nearby town between 2004 and 2006 confirmed 11 DENV infections among 102 episodes studied with DENV IgM detection, reverse transcriptase-polymerase chain reaction, and virus isolation; DENV-3 was isolated. Because DENV exposure is associated with migration or travel, personal protection measures when visiting high-risk urban areas may reduce the incidence of DENV infection in this rural population.
INTRODUCTION
Dengue is the most important arboviral disease of humans, with 2.5 billion people at risk worldwide and 50 million new infections each year, mostly in Southeast Asia, Western Pacific, and the Americas (World Health Organization website; http://www.who.int/ctd/dengue/burdens.html). After the successful eradication of Aedes aegypti in the mid-1950s, Brazil remained free of known dengue vectors until 1976. 1 Dengue virus (DENV) was reintroduced into northern Brazil in 1981 and has been spreading throughout the country since 1986. 2 Over the past 10 years, Brazil has contributed 70% cases of dengue fever reported in the Americas, 3 with 345,922 cases and 67 deaths recorded in 2006 (Ministry of Health of Brazil, unpublished data).
Urban populations are the main targets of dengue control programs worldwide, but DENV is also spreading to rural areas in several Asian countries, such as Thailand, 4, 5 Malaysia, 6 and India. 7, 8 However, it remains uncertain what favors DENV transmission in these settings.
The spread of DENV transmission to rural areas in the Americas might represent a formidable challenge to dengue control strategies. Serologic evidence of DENV exposure has been documented in rural communities in the Amazon Basin of Peru in the 1990s, 9, 10 but no data are available for other rural Amazonian populations. Here we describe the epidemiology of DENV infection in one of the largest agricultural settlements in the Amazon Basin of Brazil: the Pedro Peixoto settlement in the state of Acre. We analyze individual and household-level risk factors for the presence of DENV antibodies at baseline and for seroconversion after 6-12 months of follow-up. We discuss the prospects for dengue control in this and other similar rural settings.
MATERIALS AND METHODS

Study area.
The state of Acre is located in the Western Amazon Basin of Brazil, bordering with Peru, Bolivia, and the Brazilian states of Amazonas and Rondônia ( Figure 1 ). The study site, Ramal do Granada (9°41Ј S-9°49Ј S, 67°05Ј W-67°07Ј W), was formerly a sparsely populated rubber tapper settlement in the eastern corner of Acre that became part of the Pedro Peixoto Agricultural Settlement Project ( Figure  1 ) in 1982. The area is characterized by a humid equatorial climate and receives most rainfall (annual average, 2,198.5 mm) between December and March. The mean annual temperature is 24.5°C. Most inhabitants are migrants from southeast and south Brazil. Subsistence agriculture and cattle raising are currently the main economic activities, with coffee, banana, and rice as the main cash crops.
Baseline seroprevalence study. Recruitment strategies have been described elsewhere. 11 Briefly, all households, enumerated during a census performed by our field team in Ramal do Granada, were visited between March and April 2004, and 466 dwellers < 1-90 years of age (98.5% of the 473 areaЈs permanent residents) were enrolled. An additional 43 individuals (mostly newcomers to the area) were enrolled between September and October 2004. The 425 study participants older than 5 years of age who were enrolled either in March-April or September-October 2004 were invited to contribute a 5-mL venous blood sample for serum separation. Of these, 405 subjects (95.3% of the eligible; age range, 5-90 years), living in 122 households, had their sera tested for DENV IgG antibodies and constituted the population sample analyzed in the baseline seroprevalence survey. The location of all households was determined using a hand-held, 12-channel global positioning system receiver (eTrex Personal Navigator; Garmin, Olathe, KS), which gives a positional ac-curacy within 15 m. A baseline questionnaire was applied to study participants to obtain demographic, clinical, and socioeconomic information. Data on housing conditions, land tenure, past dengue episodes, yellow fever vaccination status, use of bed nets, and ownership of 13 household assets were recorded.
Information on household assets was used to derive a wealth index, as described by Filmer and Pritchett. 12 Principal component analysis was used to define the household asset weights. The first principal component explained 36.0% of the variability and gave the greatest weights to ownership of a refrigerator (0.831), a television set (0.773), and a parabolic antenna (0.765). Principal component analysis was carried out using the XLSTAT software, version 7.5.2 (Addinsoft, New York, NY). After standardization of these weighted asset variables, 12 the highest scores were given to the ownership of a videotape player/recorder (1.310), a sofa set (0.770), and a motor vehicle (0.760). The lowest scores were assigned to households without a refrigerator (−1.300), a gas stove (−1.020), or a blender (−0.960). The asset scores were summed to a wealth index for each household (range, −8.850 to 7.520).
Seroconversion study. All households were revisited in February-March 2005. Of 405 subjects enrolled at baseline, 380 (93.8%) still lived in the area and were eligible for a second blood sample draw. The 310 study participants with paired serum samples tested for DENV antibodies with ELISA (76.5% of the original study population; age range, 5-79 years) comprised the population sample of the seroconversion study.
Surveillance of acute febrile illnesses. The clinical and laboratory surveillance of acute febrile illnesses started in Ramal do Granada in March 2004. Because both Plasmodium falciparum and P. vivax are locally endemic, 11 all febrile patients were screened for malaria parasites by standardized thicksmear microscopy. 13 Further laboratory investigations included detection of IgM antibodies to DENV and West Nile virus (WNV), amplification of DENV RNA by reverse transcription-polymerase chain reaction (RT-PCR), and virus isolation using the C6/36 cell system, in acute-phase serum or plasma samples.
Because the number of cases of dengue fever reported in the state of Acre increased dramatically throughout 2004 (Figure 2) , we extended the laboratory surveillance of episodes of febrile illness of non-malarial origin to also include neighboring rural communities and the nearest town, Acrelândia. To recruit these additional subjects, we made periodic visits to malaria diagnosis outposts and enrolled febrile patients with negative microscopy for malaria parasites. Between March 2004 and October 2006, we studied 102 febrile episodes occurring in 90 subjects 6-60 years of age (mean, 28.1 years); 37 (41.1%) subjects lived in Ramal do Granada, FIGURE 1. Map of the state of Acre, northwestern Brazil, showing the study site. Ramal do Granada is part of the Pedro Peixoto Agricultural Settlement (shaded area in the inset), located 30-45 km northwest of the town of Acrelândia. The location of BR-364, the only paved highway connecting the capital of Acre (Rio Branco) to the rest of the country, is also indicated. 30 (33.3%) inhabited neighboring rural areas, and 23 (25.5%) lived in the town of Acrelandia. The samples for RT-PCR and virus isolation were stored in liquid nitrogen in the field and later shipped on dry ice; those for serologic analysis were stored at −20°C.
Antibody detection by ELISA. The serum samples collected at the study baseline and the follow-up visit were tested for DENV IgG antibodies by enzyme-linked immunosorbent assay (ELISA) at a 1:100 dilution. Antigens were prepared with Ae. albopictus C6/36 cells infected with DENV Types 1, 2, 3, and 4 and disrupted by sonication; uninfected C6/36 cells were processed in the same way for use as control antigens. Polysorb 96-well microplates (Nalge Nunc International, Rochester, NY) were coated with antigens diluted in phosphate-buffered saline (PBS) at 4°C overnight and subsequently blocked with a solution containing 5% skim milk in PBS for 1 hour at 37°C. To minimize background reactivity, sera were diluted in a blocking solution containing 10% (wt/ vol) of an extract of uninfected C6/36 cells. After a 1-hour incubation, serum samples were removed, and horseradish peroxidase-conjugated goat anti-human IgG (Dako North America, Carpinteria, CA) was added (30 minutes at 37°C), followed by the addition of 3, 3Ј, 5Ј tetramethyl benzidine chromogen solution (DADE Behring, Marburg, Germany). Net absorbance values were calculated by subtracting the absorbance readings at 450 nm of control antigen wells from those of DENV antigen wells. A cut-off absorbance value was defined as the mean net absorbance reading for 30 negative control sera plus 3 SD. Antibody levels were expressed in ELISA units, interpolated from a standard curve prepared with an in-house reference serum, as described elsewhere. 5 Briefly, a serum sample with known levels of anti-DENV IgG antibodies 14 was serially diluted and assayed on each of the microplates on which test sera were analyzed. Using loglinear regression analysis, net absorbance values of test sera, at 1:100 dilution, were compared with those of the standard curve to give antibody levels in arbitrary ELISA units. The cut-off absorbance value was set at 100 ELISA units; greater values were considered positive.
Paired serum samples were tested side-by-side on the same microplate. When the comparison of paired samples showed seroconversion or an increase > 4-fold in ELISA units, we determined the avidity of specific IgG antibodies by incorporating a 10-minute incubation with 7 M urea 14 into the original test protocol of the DENV IgG DxSelect kit (Focus Diagnostics, Cypress, CA). The avidity index was calculated as the percentage of decrease in absorbance readings in ureacoated wells compared with non-urea controls.
14 All ELISAbased IgG antibody assays were performed at the Laboratory of Virology of the Institute of Tropical Medicine of São Paulo.
Ninety-one acute-phase serum samples were tested for IgM antibodies using the DENV IgM Capture DxSelect kit (Focus Diagnostics), following the manufacturer's instructions. Although WNV has never been found to infect humans in Brazil, we also tested 88 acute-phase sera for specific Antibody detection by plaque reduction neutralization tests. When recent exposure to DENV was suspected based on ELISA results (seroconversion or an increase > 4-fold in ELISA units in paired serum samples), the paired serum samples were further tested using neutralization assays for DENV Types 1, 2, and 3 and also for yellow fever virus (YFV). 15 Plaque reduction neutralization tests (PRNTs) for antibodies to DENV were performed in 24-well tissue culture plates with serial 2-fold dilutions of inactivated serum samples (final volume, 50 L), starting at either 1:10 (DENV-3) or 1:11 (DENV-1 and -2) dilution. A 150-L virus suspension with 30 plaque-forming units (PFU)/well was incubated with diluted test sera for 1 hour at 37°C in 5% CO 2 ; the negative control consisted of medium without serum. Previously prepared monolayers of Vero cells (0.2 × 10 5 cells/mL) were inoculated with 200 L of each virus-serum mixture. Both virus and serum samples were diluted in 199 medium containing Earle salts, 5% fetal calf serum, 0.22% sodium bicarbonate, and antibiotics. After a 1-hour incubation at 37°C, the supernatant of each well was discarded and replaced with medium containing 3% carboxymethyl cellulose (final volume, 3 mL). The cultures were incubated for 7 days at 37°C in 5% CO 2 . The monolayers were fixed with formalin and stained with crystal violet, and plaques were counted. The serum dilution that reduces the plaque numbers by 50%, relative to the virus control, was determined by log-linear regression; neutralizing antibody titers were expressed as the reciprocal serum dilution giving 50% plaque reduction. PRNTs for antibodies to YFV were carried out in 96-well tissue culture plates with serial 2-fold dilutions of inactivated serum samples, starting at 1:5 dilution (final volume, 50 L).
15 YFV (25 PFU) in 50 L was dispensed into wells; dilutions of both virus and serum samples were performed in 199 medium containing 2.5% 1 mol/L HEPES. A positive control (monkey serum with yellow fever antibody concentration calibrated against a WHO International Reference Preparation) was included in each test. After incubation for 1 hour at room temperature, 50 L of a Vero cell suspension in 199 medium (1.6 × 10 5 cells/well) was added to the wells, with a further incubation for 3 hours at 37°C. The medium was discarded and replaced with 199 medium containing 3% carboxymethyl cellulose (final volume, 100 L). After incubation for 7 days at 37°C in 5% CO 2 , the monolayers were fixed with formalin and stained with crystal violet, and the plaques were counted. Log-linear regression analysis was used to estimate the serum dilution leading to a 50% reduction in plaque numbers relative to the virus control. Antibody levels were expressed in mIU/mL, using the reference serum preparation in a calibration curve. 16 All PRNTs were performed at the Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
RNA extraction, reverse transcriptase-polymerase chain reaction, and complementary DNA sequencing. Molecular diagnosis of DENV was carried out independently, in two laboratories, on 69 acute-phase serum or plasma samples. At the Laboratory of Molecular Biology of Marília Medical School, viral RNA was isolated from 300-L aliquots of serum or plasma as described, 17 and reverse transcriptasepolymerase chain reaction (RT-PCR) for DENV was performed with the method proposed by Lanciotti and others. 18 At the Laboratory of Virology of the Faculty of Medicine of São José do Rio Preto, samples were analyzed with novel multiplex-nested-PCR (M-N-PCR) and nested-PCR (N-PCR) assays that detect several flaviviruses (DENV-1 to -4, YFV, WNV, St. Louis encephalitis, Rocio, Bussuquara, and Iguape) and alphaviruses. 19 Briefly, RNA was extracted from 140-L aliquots of serum or plasma using the QiAampViral RNA Mini Kit (Qiagen, Hilden, Germany), and the first RT-PCR was performed using generic oligonucleotide primers for flaviviruses and alphaviruses. After the second PCR, with the species-specific primers described elsewhere, 19 the amplicons were loaded onto 1% agarose gels and visualized under UV illumination. Standard precautions to avoid contamination were followed, and both positive and negative controls were used in all reactions. Samples were coded and examined in a blinded fashion at both laboratories; results obtained independently by each laboratory were only compared at the end of the study.
DENV amplicons corresponding to a fragment of the NS5 gene were purified and sequenced using BigDye v3.1 terminator chemistry (Applied Biosystems, Foster City, CA) on an ABI377 automatic DNA sequencer (Applied Biosystems). Nucleotide sequences were analyzed using the DS Gene 2.0 software (Accelrys, San Diego, CA) and deposited into the GenBank database (accession numbers: EU672811-EU672815). The partial NS5 gene nucleotide sequences were aligned with homologous sequences from 136 DENV-3 isolates collected worldwide to build a linearized neighborjoining phylogeny using MEGA 4.0 software. 20 Bootstrap support values were obtained with 1,000 pseudoreplicates. The Appendix available online provides the complete list of sequences (with GenBank accession numbers, country, and date of isolate collection), the complete sequence alignment, and the neighbor-joining phylogeny based on 407 bp of the NS5 gene sequence in a total of 141 DENV-3 isolates. Partial NS5 gene sequences have been previously used in phylogenetic analyses of DENV-3 isolates from South America, with results consistent with those based on more extensive DNA sequencing. 21, 22 Dengue virus isolation. Virus isolation was performed for 59 acute-phase samples by inoculating 30 L of clinical specimens onto confluent monolayers of Ae. albopictus C6/36 cells in 25-cm 2 tissue culture flasks. The virus isolates were typed by indirect fluorescent antibody test with serotype-specific monoclonal DENV antibodies. 23 Virus isolation and identification were performed, following identical protocols, at the Laboratory of Arbovirology and Hemorrhagic Fevers, Evandro Chagas Institute, Belém, and at the Laboratory of Molecular Biology of Marília Medical School, Marília.
Definitions. We used two combinations of ELISA results to select samples with a possible evidence of DENV infection during the follow-up (seroconversion study): 1) the first (baseline) sample was IgG-negative but the second sample (February-March 2005) was IgG-positive, irrespective of the levels of specific antibodies, or 2) DENV IgG levels (measured in ELISA units) increased by > 4-fold when comparing paired serum samples. To confirm that these changes in ELISA antibody units resulted from recent exposure to DENV, the subset of paired samples selected as described above was further examined with PRNTs for DENV (Types 1, 2, and 3) and YFV. The final criteria for defining recent exposure to DENV in this subset of samples were 1) the baseline sample was negative but the second sample was PRNT positive for at least one DENV type, or 2) there was a > 3-fold increase in PRNT antibody titers to at least one DENV type in paired samples. For convenience, both situations will be termed "seroconversion" throughout the article. Acute DENV infection was defined as 1) DENV isolation in acute-phase serum or plasma, 2) amplification of DENV RNA by RT-PCR (with either protocol) in acute-phase serum, 3) detection of DENV IgM by ELISA in acute-phase serum, or 4) PRNT antibody seroconversion (as defined above).
Data analysis. A database was created with SPSS 13.0 (SPSS, Chicago, IL). The incidence of dengue was estimated as the number of seroconverters per 100 person-years at risk, and its exact Poisson 95% confidence interval (CI) was calculated, with time at risk defined as time interval between blood draws. Multiple logistic regression models with stepwise backward deletion were built to describe independent associations between potential risk factors (independent variables) and two outcomes: 1) positive DENV serology at the study baseline and 2) seroconversion (defined by PRNT results) during the study. Variables associated with P < 0.20 in unadjusted analysis were included into the logistic regression models. Because the data have a nested structure, where individuals are nested within households, the assumption of independence of observations underlying standard logistic regression analysis was violated. We therefore used multilevel logistic models with individual and household-level risk factors. 24 The HML software package (version 6.03; Scientific Software International, Lincolnwood, IL) was used for multilevel analysis. Only variables associated with statistical significance at the 5% level were maintained in the final models.
The Kulldorff spatial scan statistics was used to test whether DENV infections were randomly distributed within the study area and to identify significant spatial clusters, if present. 25 Analysis was made using the Bernoulli model implemented in version 5.1 of the SaTScan software (available at http://www.satscan.org), which creates and moves circular windows systematically throughout the geographic space to identify significant clusters of infections. The windows are centered on each household; the largest possible cluster was set to encompass 50% of the households. For each location and size of the scanning window, SaTScan performs a likelihood ratio test to evaluate whether infections are more prevalent within that specific circular window compared with the outside. Separate analyses were made for 1) DENV IgG seropositivity at the study baseline and 2) PRNT-confirmed seroconversion during the study. P values were determined by 10,000 Monte Carlo replications of the data set, and a level of significance of 5% was adopted.
Ethical considerations. Approval of the study protocol was obtained from the Ethical Review Board of the Institute of Biomedical Sciences of the University of São Paulo, Brazil (538/2004). Written informed consent was obtained from all study participants or their parents/guardians.
RESULTS
Prevalence of antibodies at baseline and associated risk factors. DENV IgG antibodies were detected in 74 subjects 5-77 years of age (mean, 33.8 years) examined at the study baseline (seroprevalence rate, 18.3%; 95% CI, 14.6-22.4%). Both individual (age, sex, and migration history) and household-level (wealth, land tenure, and housing conditions) characteristics were significantly associated with the presence of DENV IgG antibodies in unadjusted analysis (Table 1 ). Many household characteristics that might facilitate the transmission of mosquito-borne infections were fairly homogeneous. For example, all houses had windows that could be closed, but none of them had screens. Cross-reactivity among flaviviruses could affect DENV antibody measurements in populations exposed to, or immunized against, yellow fever. In fact, subjects with antibodies to the vaccinal strain of YFV (17DD) used in Brazil, detected by HIA, 26 were considerably more likely to have DENV IgG antibodies detected by ELISA (OR ‫ס‬ 18.74; 95% CI, 8.89-39.80; P < 0.0001; 355 sera analyzed; data from Silva-Nunes and others 11 ). However, although 87.2% of the study subjects reported yellow fever vaccination over the past 10 years, DENV IgG antibodies detected by ELISA were similarly prevalent in recently vaccinated and non-vaccinated subjects (Table 1 ). This finding suggests that recent yellow fever vaccination has not substantially affected DENV antibody measurements in our population. The same conclusion was reached in a recent survey comparing HIA antibody titers to DENV and 17D yellow fever virus before and after the mass vaccination campaign against yellow fever carried out in Acre in 2000; 3 months after vaccination, 92.1% of the vaccinees had HIA antibodies to 17D yellow fever virus (compared with 15.5% before vaccination), but only 2.1% of them seroconverted to DENV. 27 However, a more conclusive analysis of a possible interference of preexisting antibodies to YFV with DENV serodiagnosis would require the use of more specific neutralization assays.
Multilevel logistic regression analysis showed that male sex, low wealth index, and history of migration from extraAmazonian states were significant independent predictors of the presence of DENV IgG antibodies at baseline (Table 2) , whereas self-reported past DENV infection was a predictor of borderline statistical significance. The association between age and DENV seropositivity was no longer significant after (Table 1) . DENV infection during the follow-up and associated risk factors. Of the 310 subjects who contributed paired serum samples, four had > 4-fold increases in DENV IgG levels and 16 had a seroconversion detected by ELISA. DENV IgG antibody avidity was assessed for 16 of these subjects, and only 2 had antibodies of low avidity (< 30%) in the second sample, which are suggestive of a very recent primary DENV infection.
14 Avidity could not be assessed properly in four samples with low levels of DENV IgG antibodies detected by ELISA. To confirm whether the observed changes in ELISA antibody units in paired samples resulted from recent exposure to DENV, the samples were further tested by PRNT. The comparison of paired titers of antibodies to DENV and YFV (the only other flavivirus known to circulate in the study area) in paired samples, shown in Table 3 , confirmed 10 of 20 instances of recent exposure to DENV suggested by ELISA. Three DENV seroconverters (Subjects 17, 172, and 229) also had > 3-fold increases in the PRNT titers of antibodies to YFV ( Table 3 ), suggesting that they might have been recently exposed to either wild-type YFV or yellow fever vaccine. However, given the very little (if any) cross-reactivity observed between the antibodies to DENV and YFV in PRNT, 28 we consider the large increases in DENV-specific PRNT antibody titers in these three subjects to be clearly diagnostic of recent exposure to the virus. The PRNT-confirmed seroconversion rate was therefore estimated as 3.67 episodes/100 person-years at risk (95% CI, 2.24-5.67 episodes/100 personyears). Two findings suggest that the clinical diagnosis of dengue fever is neither sensitive nor specific in this malariaexposed population: 1) only 4 of 24 subjects reporting a clinically diagnosed dengue fever episode during the followup actually seroconverted and 2) most seroconverters (6 of 10) reported no dengue fever episode diagnosed on clinical grounds during the follow-up.
The small number of confirmed seroconversion events reduces the statistical power of risk factor analysis, but a selfreported history of clinical diagnosis of dengue fever and of travel to Rio Branco (the capital of Acre) during the followup emerged as strong predictors of seroconversion in unadjusted analysis (data not shown). Participants in the seroconversion study (N ‫ס‬ 310) were older (mean age, 28.3 versus 23.5 years; P ‫ס‬ 0.021, Mann-Whitney test) and wealthier (mean wealth index, 0.26 versus -3.52; P < 0.001, MannWhitney test) than the subjects who failed to provide a second serum sample (N ‫ס‬ 95). However, univariate analysis showed no significant difference in predictors of seroconversion between the two groups. Multilevel logistic regression analysis showed male sex, in addition to the predictors shown by unadjusted analysis, to be significantly associated with seroconversion during our study (Table 4) .
Spatial analysis. The Kulldorf spatial scan statistic showed no significant spatial clustering of households inhabited by the 74 subjects with DENV IgG antibodies detected at baseline. A similar analysis involving the 10 documented episodes of seroconversion confirmed by PRNT also failed to show any significant spatial clustering.
Laboratory investigation of acute febrile illnesses. Only 11 (10.8%) of 102 non-malarial febrile episodes studied between 2004 and 2006 had any laboratory evidence of acute DENV infection: 1) RT-PCR and virus isolation were both positive for DENV-3 in two episodes, 2) RT-PCR alone was positive for DENV-3 in three episodes; 3) DENV IgM together with PRNT seroconversion were detected in two episodes, 4) DENV IgM was detected in acute-phase sera from three episodes for which seroconversion analysis could not be made, and 5) PRNT seroconversion was detected in one subject with IgM-negative acute-phase sera. Sequential serum samples for seroconversion analysis were available for only 28 subjects who contributed acute-phase serum. Both RT-PCR assays were positive for DENV-3 in two samples, whereas only the method described by Bronzoni and others 19 was able to detect DENV-3 RNA in three samples. No acute-phase sample was positive for YFV or any other flavivirus tested, arguing against a major impact of antibodies elicited by exposure to other flaviviruses on the observed serologic patterns.
We noticed several discrepancies when comparing different laboratory methods. For example, three IgM-positive acutephase sera yielded negative RT-PCR, and one was also DENV isolation negative; the remaining IgM-positive samples were not tested by either method. In addition, the acute-phase serum from one seroconverter tested negative for IgM antibodies and two acute-phase sera from seroconverters were negative by both RT-PCR and virus isolation. Both acute-phase samples with DENV detected by virus isolation were IgM negative. These inconsistencies are expected in field studies, because the timing of acute-phase sample draws may be appropriate for some but not all diagnostic methods used. For instance, RT-PCR and cell culture isolation are more effective during early infection, whereas MAC-ELISA becomes more sensitive later on. In this study, the low viral loads at the time of blood collection may have reduced the diagnostic sensitivity of virus isolation and RT-PCR in some subjects, whereas high levels of preexisting antibodies to DENV may have impaired the detection of seroconversion events in other subjects.
The acute-phase samples from which DENV-3 was isolated were collected from two residents in the town of Acrelândia presenting with a clinical diagnosis of dengue fever in November 2004 and February 2006, respectively. In both samples, virus identification was confirmed by sequencing 407 bp of the NS5 gene fragment amplified as described by Bronzoni and others. 19 We also sequenced the DENV-3-specific RT-PCR products amplified from three acute-phase samples (derived from two residents in the town of Acrelân-dia and one resident in the rural study site) that were negative for virus isolation (collected in December 2004, February 2005, and February 2006). The five partial NS5 gene sequences from Acre were aligned with 136 GenBank-available homologous sequences from DENV-3 isolates collected worldwide. The neighbor-joining phylogeny built with these sequence data grouped all isolates from Acre together with seven DENV-3 isolates from Brazil and six from Martinique in a clade with 85% bootstrap support (Appendix available online at www.ajtmh.org). These data give further support further support to the claim that most DENV-3 isolates circulating in Brazil have Caribbean origin. 29 The DENV-3 sample found in November 2004 corresponds the first isolation of this DENV type in Acre, although DENV-3 had already been found to circulate in the neighboring states of Amazonas and Rondônia since 2002. 30 Because Acrelândia is located close to the only highway (BR-364) connecting Acre to the rest of the country (Figure 1 ), this town is the most likely port of entry of DENV-3 into Acre, leading to the 2004 outbreak that mostly affected Rio Branco, situated about 120 km west of this town (Figure 2) . Unfortunately, no further DENV-3 isolates from the outbreak are available to sequence analysis to confirm the putative route of entry of DENV-3.
DISCUSSION
The first population-based study of DENV infection in a rural Amazonian population of Brazil showed a low baseline DENV seropositivity rate (18.3%) with a sizable seroconversion rate (3.67 episodes/100 person-years at risk) over the next 12 months. These findings reflect the relatively recent introduction of DENV into Acre, with the occurrence of a dengue outbreak during the study period (Figure 2) . Acre was the last state in the Amazon Basin of Brazil to report autochthonous infections with DENV-1 and -2. 30 Not surprisingly, the overall DENV seroprevalence in the city of Rio Branco was estimated to be only 4.4% in August 1999, with only antibodies to DENV-1 and -2 detected by HIA. 27 The incidence rate of DENV infection during the follow-up is lower than that recently estimated for areas with stable transmission in Southeast Asia, such as northern Thailand 31 (8.5 episodes episodes/100 person-years) and southern Vietnam 32 (11.7 episodes/100 person-years), and in the Americas, such as Nicaragua 33 (6.0-12.0 episodes/100 person-years). Because of the long period between blood draws, we may have missed some DENV infections occurring soon after the baseline survey, thus underestimating the incidence rate. Sequential HIAs performed at 6-month intervals detected 97% of the incident asymptomatic DENV infections in Thailand, 31, 34 was significantly associated with seropositivity at baseline (Tables 1 and 2 ), whereas a history of travel to Rio Branco, where a major dengue fever outbreak occurred in 2004 (Figure 2) , predicted seroconversion during follow-up (Table 4) . Although 2 of 10 seroconverters reported no travel to Rio Branco during the follow-up, short visits to the town of Acrelândia (30-45 km away) and other urban centers could not be ruled out. Significantly, four of five DENV-3 infections confirmed by RT-PCR during our study were diagnosed in residents in the town of Acrelândia, confirming that this virus circulated in this urban area. The lack of significant spatial clustering of DENV infections in Ramal do Granada further supports the hypothesis of little autochthonous transmission in the rural settlement. No larvae or adults of known DENV vector species have been found in Ramal do Granada over the past 5 years, but sampling may have been biased because most of the local entomologic research focuses on malaria vectors. 11 As pointed out in a similar study carried out in the Peruvian Amazonia, vector control is inappropriate for DENV control in rural areas where little autochthonous transmission occurs. 10 Personal protection measures when visiting high-risk urban centers might be more effective to prevent DENV infection in this and other similar rural populations. Learning the reasons why inhabitants in rural areas often visit urban centers may also aid in designing more effective strategies to minimize the risk of DENV introduction into their communities. Significant sex differences in DENV infection rates have been described in several studies. 35 Hospital-based studies in Asia have suggested that infections are more frequent in men, but these data may simply reflect sex-related differences in healthcare-seeking behavior. 35 In contrast, the only population-based study comparing DENV infection rates according to sex in the Americas was carried out in Mexico and found an increased risk among women. 36 The risk of past DENV infection at baseline and that of subsequent infections during the follow-up remained significantly higher among men, in our study, after controlling for migration patterns and travel history, suggesting that sex-related differences in exposure are unlikely to account for these findings. The biological bases for male-female differences in DENV infection rates remain undetermined. Sex differences in immune responses elicited by DENV in men and women have been put forth as an explanation for male predominate among patients with mild disease, whereas women predominate in more severe cases in Southeast Asia. 37 However, this hypothesis has yet to be further explored.
The association between low socioeconomic status and DENV infection rates has been described in both Southeast Asia and the Americas, 35 although discordant results have been reported in urban Brazil. 38 Because baseline DENV seropositivity remained significantly associated with poverty after controlling for migration history (Table 2) , povertyrelated differences in migration patterns are unlikely to account for this finding in our population. If most DENV infections are not locally acquired, differences in housing conditions 32, 35 are unlikely to account for this association, either. Poverty, however, did not predict the risk of seroconversion during the follow-up.
Although standardized diagnostic criteria 39 are widely used, the clinical diagnosis of DENV infection in Brazil remains notoriously inaccurate, [40] [41] [42] because several locally prevalent febrile illnesses may be misdiagnosed as dengue fever. Here we show that 1) dengue accounted for only 11 of 102 (10.8%) febrile episodes of non-malarial origin occurring in patients from rural and urban areas of eastern Acre, 2) even though a self-reported history of dengue diagnosis was a strong predictor of seroconversion during the follow-up (Table 4) , only 4 of 24 subjects self-reporting a dengue fever episode during the follow-up actually seroconverted, and 3) most (6 of 10) of those with PRNT-confirmed DENV seroconversion reported no clinically diagnosed dengue fever episode during the follow-up. Most DENV infections in these subjects may have been asymptomatic. These findings underscore the need for laboratory confirmation of DENV infections for outbreak investigation and disease surveillance. 43 Accordingly, our laboratory surveillance showed the circulation of DENV-3 in the urban area of Acrelândia since November 2004 , suggesting that the introduction of this serotype led to the dengue fever outbreak recorded in Acre in the second semester of 2004. Nine cases of dengue hemorrhagic fever, four leading to death, were laboratory-confirmed in Acre in 2004 (Ministry of Health of Brazil, unpublished data available at http://portal.saude.gov.br/portal/svs/area.cfm?id_ area‫.)154ס‬ If the patterns of DENV circulation in the most likely ports of entry to Acre (including Acrelândia) were known earlier, classic preventive measures, such as vector control, could have been timely implemented in the urban areas that were mostly affected, thus reducing the morbidity and mortality associated with the outbreak and minimizing the risk of infection among nearby rural populations who often visit urban areas.
Note: Supplemental material (Appendix) appears online at www .ajtmh.org.
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